Journal of the Medical Sciences (Berkala Ilmu Kedokteran)
Vol 51, No 2 (2019)

Mode of action of tocotrienol as anticancer

Widiyasri Lodu (Graduate Student of Master of Biology Program, Satya Wacana Christian University. Salatiga, Jawa Tengah)
Ferry Fredy Karwur (Graduate Student of Master of Biology Program, Satya Wacana Christian University. Lecturer Faculty of Medicine and Health Science, Satya Wacana Christian University. Salatiga, Jawa Tengah.)



Article Info

Publish Date
02 Jul 2019

Abstract

Tocotrienols are fat soluble substances members of the vitamin E family with the main properties of antioxidant. They are composed of the chiral center of chromanol ring with polypreniyl side chains. Research suggests that tocotrienols have a number of health benefit, and one of them as an anticancer agent. As an anticancer, tocotrienols could perform in different processes of the multi stages of cancer development and interact with other anticancer medicines and other bioactive substances, suchs geneistein, lovastin, hydroxychavicol, 6- gingerol and sesamin. The anticancer activities occur through their roles as antioxidant, coenzyme, gene expression regulator, and preventing cholesterol synthesis by inhibiting the expression of HMGCR enzyme after transcription, through this method, tocotrienols could control the cholesterol level of cancer cells and prevent the growth of the cancer. Tocotrienols target several signalling pathways at cellular and molecular levels.

Copyrights © 2019






Journal Info

Abbrev

bik

Publisher

Subject

Immunology & microbiology Neuroscience

Description

Journal of the Medical Sciences (JMedSci) or Berkala Ilmu Kedokteran (BIK) is an international, open-access, and double-blind peer-reviewed journal, published by Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada Yogyakarta Indonesia. JMedSci aiming to communicate high-quality ...